214260 — Raphas Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩186bn
- KR₩204bn
- KR₩28bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 21,635 | 20,596 | 52,743 | 39,221 | 39,877 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,054 | 2,860 | 4,441 | 4,357 | 6,710 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 29,035 | 26,486 | 60,887 | 49,050 | 52,257 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22,219 | 22,877 | 25,708 | 31,855 | 32,580 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 62,885 | 59,827 | 97,844 | 96,060 | 100,405 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,998 | 5,388 | 35,996 | 44,378 | 62,169 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,052 | 15,646 | 45,485 | 55,133 | 70,863 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 47,833 | 44,181 | 52,359 | 40,927 | 29,541 |
Total Liabilities & Shareholders' Equity | 62,885 | 59,827 | 97,844 | 96,060 | 100,405 |
Total Common Shares Outstanding |